Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) EPS (Weighted Average and Diluted) (2021 - 2025)

Aethlon Medical filings provide 6 years of EPS (Weighted Average and Diluted) readings, the most recent being $39.77 for Q1 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 213.89% to $39.77 in Q1 2025 year-over-year; TTM through Mar 2025 was $10.85, a 127.92% increase, with the full-year FY2025 number at -$8.58, up 77.93% from a year prior.
  • EPS (Weighted Average and Diluted) hit $39.77 in Q1 2025 for Aethlon Medical, up from -$10.05 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $39.77 in Q1 2025 to a low of -$34.92 in Q1 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$1.23 (2022), compared with a mean of -$2.06.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 3323.53% in 2024 and later soared 213.89% in 2025.
  • Aethlon Medical's EPS (Weighted Average and Diluted) stood at -$0.16 in 2021, then plummeted by 675.0% to -$1.24 in 2022, then fell by 10.48% to -$1.37 in 2023, then tumbled by 633.58% to -$10.05 in 2024, then soared by 495.72% to $39.77 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $39.77 (Q1 2025), -$10.05 (Q4 2024), and -$16.11 (Q3 2024) per Business Quant data.